CURRICULUM VITAE

NAME: PIETER MARTEN TER WEE

terwee

 

DOB   1 April 1957
       
PRIVATE ADDRESS              

Walstro 11

3641 VM Mijdrecht

  The Netherlands
  tel: ++31-297-281658
   
BUSINESS ADDRESS

VU University Medical Center
 

Department of Nephrology
 

PO-box 7057

 

tel:  ++31-20-4442673
 

fax: ++31-20-4442675
 

NL-1007 MB Amsterdam
   
E-mail:

pm.terwee@vumc.nl

      
        
EDUCATION
1969-1975

Gymnasium ß.

1975-1982

Medical school, Groningen, The Netherlands. Physician’s degree: 3 juni 1982.
1-7-’82 till 31-12-’84 houseofficer Intensive Care of the department of Internal Medicine, State University Hospital (Head: dr. A.J.M. Donker).
1-1-’85 till 1-10-’90

residency Internal Medicine at the Departments of Internal Medicine of the State University Hospital Groningen and the Academic Hospital Vrije Universiteit Amsterdam.
1-1-’90 till 1-1-’92

fellowship Neprhology (head: prof. dr. A.J.M. Donker).
1-1-’92 till 1-8-’93

post-doctoral fellowship at the laboratory for renal microcirculation of prof. dr. M. Epstein, University of Miami, U.S.A.
1-8-’93 till 1-11-’95

consultant in Nephrology, department of Medicine, Academic Hospital Vrije Universiteit Amsterdam.
1-10-’94

managing head of the department of Nephrology of the Academic Hospital Vrije Universiteit Amsterdam (head: prof. dr. A.J.M. Donker).
1-11-’95 till 1-11-2000

associate professor in Nephrology Academic Hospital Vrije Universiteit Amsterdam.
1-11-200 till….:

Professor in Nephrology and head of the Department of Nephrology, VU University Medical Center, Amsterdam.
   
   

THESIS

Februari 11th 1987. Title: Renal reserve filtration capacity in man.
 
 

Management and committees within VUmc

  • 1996-998: member of the Medical Faculty advisory board
  • 1996-now: member of the hospital physician advisory board ‘stafconvent’
  • 1998-2001: chairman of the office space advisory board ‘Interne Geneeskunde’
  • 1998-1998: chairman Medical Faculty ICT-advisory board
  • 1999-2006: member hospital committee on evaluating medical/nursing mistakes
  • 1999-2004: secretary research foundation ‘Stichting Medicina Interna’
  • 2004-now: chairman research foundation ‘Stichting Medicina Interna’
  • 2001-now: chairman elect division 1
  • 2003-now: member hospital IT-board
  • 2005-now: chairman hospital library committee
  • 2006-now: head department of Endocrinology ad interim

 

Committees outside VUmc

  • 1996-1998: member committee on guidelines and quality improvement Dialyse Groep Nederland
  • 1998-2007: chairman of the committee on guidelines and quality improvement of the Dutch Federation of Nephrology
  • 1996-1998: member ICT advisory board Dialyse Groep Nederland
  • 1998-now: auditor of dialysis facilities and member auditor board of the Dutch Federation of Nephrology
  • 1998-2003: secretary of the national committee on training in Nephrology of the Dutch Federation of Nephrology
  • 2003-2007: chairman of the national committee on training in Nephrology of the Dutch Federation of Nephrology
  • 1999-2003: member of the ‘European committee on guidelines for haemodialysis’ wave 1
  • 2003-2007: member of the ‘European committee on guidelines for haemodialysis’ wave 2
  • 1999-2007: member of the board of the Dutch Federation of Nephrology
  • 2007-now: president of the Dutch Federation of Nephrology
  • 2005-2007: chairman of the board of RENINE
 

Teaching

  • 1997-now: teacher in several classes Nephrology at the VUmc
  • 1998-now: organizer and teacher in several topics at the national training days of the Dutch Federation of Nephrology
  • 2000-now: cofounder and organizer of the winterschool of the Dutch Kidney Foundation (2006-now: chairman of the organizing committee)
 
Research topics

Biocompatibility of dialysis

  • Biocompatibility of peritoneal dialysis: preclinical studies in vitro and in rats, clinical studies. Several grants of the Dutch Kidney Foundation and Baxter healthcare.
  • Rabit model for the study of biocompatibility of hemodialysis.

Cardiovasculair complications in renal failureIntradialytic hypotension: prevalence, the role of hypovolemia and the effect of interventions (Dutch Kidney Foundation 94.1391)

  • Hyperhomocystenemia and renal disease. (Dutch Kidney Foundation 94.1355)
  • ATIC: P Nanyakara (Dutch Kidney Foundation)
  • Renal microcirculation by means of hydronephrotic rat kidney model:
  • The effects of angiotensin II on the renal microcirculation: differences between afferent and efferent arterioles. (Dutch Kidney Foundation 94.1423)
  • Postdoc W. van Rodijnen (Dutch Kidney Foundation)
  • Diabetes: M. Roos (Dutch Kidney Foundation)
  • Renal and hemodynamic effects of exogenous insulin and ANP (Dutch Kidney Foundation 94.1378 and 95.1443).
  • CONTRAST: multicenter study on mortality and cardiovascular outcome on hemodiafiltraion versus standard hemodialysis (Dutch Kidney Foundation; Gambro, Fresenius medical care, Baxter healthcare, Roche, Twisk fund)
 

English publications (peer-reviewed)

  1. Rosman JB, ter Wee PM, Piers-Becht GPM, Sluiter WJ, van der Woude FJ, Meijer S, Donker AJM. Early protein restriction in chronic renal failure. Proc EDTA-ERA 21: 567-573, 1984.
  2. Rosman JB, ter Wee PM, Meijer S, Piers-Becht GPM, Sluiter WJ, Donker AJM. Prospective randomised trial of early dietary pro­tein restriction in chronic renal failure. Lancet ii: 1291-1295, 1984.
  3. ter Wee PM, van Hoek B, Donker AJM. Indomethacin treatment in a patient with lithium-induced polyuria. Intensive Care Med 11: 103-104, 1985.
  4. ter Wee PM, Kremer Hovinga TK, Uges DRA, van der Geest S. 4-Aminopyridine and haemodialysis in the treatment of verapamil intoxication. Human Toxicol 4: 327-329, 1985.
  5. Beukhof HR, ter Wee PM, Sluiter WJ, Donker AJM. Effect of low-dose dopamine on effective renal plasma flow and glo­merular filtration rate in 32 patients with IgA nephropa­thy. Am J Ne­phrol 5: 267-270, 1985.
  6. ter Wee PM, Geerlings W, Rosman JB, Sluiter WJ, van der Geest S, Donker AJM. Testing renal reserve filtration capacity with an amino acid solution. Nephron 41: 193-199, 1985.
  7. ter Wee PM, Smit AJ, Rosman JB, Sluiter WJ, Donker AJM. Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol 6: 42-46, 1986.
  8. ter Wee PM, Rosman JB, van der Geest S, Sluiter WJ, Donker AJM. Renal hemodynamics during separate and combined infu­sion of amino acids and dopamine. Kidney Int 29: 870-874, 1986.
  9. ter Wee PM, van Ballegooie E, Rosman JB, Meijer S, Donker AJM. The effect of low-dose dopamine on renal haemodynamics in pa­tients with Type 1 (insulin-dependent) diabetes does not differ from normal individuals. Diabetologia 29: 78-81, 1986.
  10. ter Wee PM, Tegzess AM, Donker AJM. The effect of low-dose dopa­mine on renal function in uninephrectomized patients: special emphasis on kidney donors before and after nephrec­tomy. Clin Nephrol 28: 211-216, 1987.
  11. ter Wee PM, van Ballegooie E, Donker AJM. Renal reserve filtra­tion capacity in patients with Type 1 (insulin-depen­dent) diabe­tes mellitus. Nephrol Dial Transplant 2: 504-509, 1987.
  12. Rosman JB, ter Wee PM. Relationship between proteinuria and response to low protein diets in early chronic renal fail­ure. Blood Purif 7: 52-57, 1989.
  13. ter Wee PM, Donker AJM. Diabetic nephropathy in insulin-depen­dent diabetic patients: renal hemodynamics and derived treat­ment strategies. J Diabetic Compl 4: 62-69, 1989.
  14. Rosman JB, Langer K, Brandl M, Piers-Becht GPM, van der Hem GK, ter Wee PM, Donker AJM. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indica­tions. Kidney Int 36: suppl. 27, S96-102, 1989.
  15. ter Wee PM, Tegzess AM, Donker AJM. Renal reserve filtra­tion capacity before and after kidney dona­tion. J Int Med 228: 393-9, 1990.
  16. ter Wee PM, Luth WJ, van der Schee AC, Stam J. Scoliosis as a cause of pulmonary atelectasis. Eur Resp J 4: 371-3, 1991.
  17. ter Wee PM, Donker AJM. Renal reserve filtration capacity: can it predict progression of chronic renal failure? Am J Kidney Dis 17 (suppl 1): 71-5, 1991.
  18. de Fijter CWH, Oe PL, Nauta JJP, van der Meulen J, ter Wee PM, Snoek FJ, Donker AJM. A prospective, randomized study compar­ing the peritonitis incidence of CAPD and Y-connector (CAPD-Y) with continuous cyclic peritoneal dialysis. Adv Periton Dial 7:186-189, 1991.
  19. Kouw PM, Olthof CG, ter Wee PM, Oe PL, Donker AJM, Schnei­der H, de Vries PMJM. Assessment of post-dialysis dry weight: an application of the conductivity measurement method. Kidney Int 1992; 41: 440-444.
  20. ter Wee PM, Donker AJM. Clinical strategies for arresting progression of renal disease. Kidney Int 1992; 42 (suppl. 38): S114-S120.
  21. ter Wee PM, Epstein M: ACE inhibitors and progression of non-diabetic chronic renal disease.  Arch Intern Med 153:1749-1759, 1993.
  22. ter Wee PM, Donker AJM: Pharmacologic manipulation of glomeru­lar function.  Kidney Int 45:417-424, 1994.
  23. ter Wee PM, Tegzess AM, Donker AJM. Pair tested renal reserve filtration capacity in kidney recipients and their donors. J Am Soc Nephrol 4:1798-1808, 1994.
  24. ter Wee PM, DeMicheli A, Epstein M: Effects of calcium antagonists on renal hemody­namics and progres­sion of non-diabetic chronic renal disease.  Arch Intern Med 154:1185-1202, 1994.
  25. van Guldener C, ter Wee PM: Reply to Hartung et al. (1993; letter). Nephrol Dial Transpl 9:737-737, 1994.
  26. Hoogenberg K, ter Wee PM, Lieverse AG, Sluiter WJ, Dullaart RPF.  Insulin-like growth factor I and altered renal hemo­dy­namics in growth hormone deficiency, acromegaly and type I diabetes mellitus.  Transpl Proceed 26:505-507, 1994.
  27. Forster HG, ter Wee PM, Takenaka T, Hohman TC, Epstein M: Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat (43773).  PSEBM 206:365-374, 1994.
  28. van Guldener C, Gans ROB, ter Wee PM: The constant infusion clearance is an inappropriate method for accurate assess­ment of an impaired glomerular filtration rate.  Nephrol Dial Transpl 10:47-51, 1995.
  29. Franssen CFM, Gans ROB, Arends AJ, Hageluken C, ter Wee PM, Gerlag PGG, Hoorntje SJ: Differences between anti-myeloper­oxi­dase- and anti-proteinase 3-associated renal disease.  Kidney Int 47:193-199, 1995.
  30. Brulez HFH, Parra Moncasi E, Posthuma N, Choy KW, ter Wee PM: The efficacy of intraperitoneally administered gentamycin and rifampin as initial treamtent of peritoneal dialysis related peritonitis. Adv Perit Dial 11:182-186, 1995.
  31. ter Wee PM: Renal effects of intravenous amino acid administration in humans with and without renal disease: hormonal correlates. Sem Nephrol 15:426-432, 1995.
  32. Janssen MJA, van der Kuy A, ter Wee PM, van Boven W-PL: Calcium acetate versus calcium carbonate and erythropoietin dosages in haemodialysis patients. Nephrol Dial Transplant 10:2321-2324, 1995.
  33. Stam F, van der Tillaar M, Falke ThHM, Gans ROB, ter Wee PM: Xanthogranulomatous pyelonephritis. Nephrol Dial Transplant 10:2365-2367, 1995.
  34. Janssen MJA, van der Kuy A, ter Wee PM, van Boven W-PL: Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent haemodialysis patients. Clin Nephrol 45:111-9, 1996.
  35. Forster HG, ter Wee PM, Hohman TC, Epstein M: Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat is prevented by tolrestat. Diabetologia 39:907-914, 1996.
  36. Brulez HFH, Dekker HAT, Oe PL, Verbeelen D, ter Wee PM, Verbrugh HA: Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid. Nephron 74:26-32, 1996.
  37. de Fijter WM, de Fijter CWH, Oe PL, ter Wee PM, Donker AJM: Assessment of total body water and lean body mass from anthropometry, Watson formula, creatinine kinetics, and body electrical impedance compared with antipyrine kinetics in peritoneal dialysis patients. Nephrol Dial Transplant 12:151-156, 1997.
  38. Posthuma N, ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, Donker AJM: Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant 12:550-553, 1997.
  39. ter Wee PM, Donker AJM: Dietary protein restriction for retardation of progression of chronic renal failure: yes or no? Int J Artif Organs 20:82-86, 1997.
  40. ter Wee PM, Forster HG, Epstein M: Video-microscopic assessment of the role of tissue angiotensin-converting enzym inhibitor in the control of the renal micorcirculation. JPET 281:434-439, 1997.
  41. ter Maaten JC, Voorburg A, Heine RJ, ter Wee PM, Donker AJ, Gans RO: Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci 92:51-58, 1997.
  42. Posthuma N, ter Wee PM, Donker AJM, Oe PL, van Dorp W, Peers EM, Verbrugh HA. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell. Perit Dial Int 17:602-607, 1997.
  43. Van Guldener C, Janssen MJFM, Lambert J, ter Wee PM, Jakobs C, Donker AJM, Stehouwer CDA: No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinemia in haemodialysis patients. Nephrol Dial Transpl 13:106-112, 1998.
  44. ter Wee PM, Gans R.O.B.: ‘A man from Surinam ...’ Nephrol Dial Transpl Nephrol Dial Transpl 13:209-210, 1998.
  45. Schrander-vd Meer AM, ter Wee PM, Donker AJM, van Dorp WT: Dialysis efficacy during acetate-free biofiltration. Nephrol Dial Transpl 13:370-374, 1998.
  46. Posthuma N, Borgstein PJ, Eijsbouts Q, ter Wee PM: Simultaneous peritoneal dialysis catheter insertion and removal in catheter-related infections without interruption of peritoneal dialysis. Nephrol Dial Transpl Nephrol Dial Transpl 13:700-703, 1998.
  47. ter Maaten JC, Voorburg A, de Vries PMJM, ter Wee PM, Donker AJM, Gans ROB: Relationship between insulin’s haemodynamic effects and insulin-mediated glucose uptake. Eur J Clin Invest 28:279-284, 1998.
  48. Van Guldener C, Janssen MJFM, Lambert J, ter Wee PM, Donker AJM, Stehouwer CDA: Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy. Perit Dial Int 18:282-289, 1998.
  49. Ter Wee PM, Donker AJM: Non-immunosuppresive therapy to retard the progression of chronic renal failure. Mitt Klin Nephrologie XXVII:17-30, 1998.
  50. Posthuma N, ter Wee PM, Donker AJM, Peers EM, Oe PL, Verbrugh HA: Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations. Nephrol Dial Transpl 13:2341-2344, 1998.
  51. Janssen JJWM, Gans ROB, van der Meulen J, Pijpers R, ter Wee PM: Comparison between the effects of amlodipine and lisinopril on proteinuria in non-diabetic renal failure: a double-blind randomized prospective study. Am J Hypert 11:1074-1079, 1998.
  52. Straver B, de Vries PMJM, ten Voorde BJ, Stevens P, Donker AJM, ter Wee PM: Intradialytic hypotension in relation to pre-existent autonomic dysfunction in hemodialysis patients. Int J Artif Organs 21:794-801, 1998.
  53. Straver B, Roggekamp MC, de Vries PMJM, ter Wee PM: Systemic vascular resistance in intradialytic hypotension determined by means of impedance cardiography. Blood Purif 16:269-274, 1998.
  54. Brulez HFH, van Guldener C, Donker AJM, ter Wee PM: The impact of an amino acids-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass. Nephrol Dial Transpl 14:154-159, 1999.
  55. Schrander-v.d. Meer AM, ter Wee PM, Kan G, Donker AJM, Dorp v WT: Improved cardiovascular variables during acetate free biofiltration. Clin Nephrol 5:304-309, 1999.
  56. Venmans BJW, van Kralingen KW, Chandi DD, de Vries PMJM, ter Wee PM, Postmus PE: Sleep complaints and sleep disordered breathing in hemodialysis patients. Neth J Med 54:207-212, 1999.
  57. Serné EH, Stehouwer CDA, ter Maaten JC, ter Wee PM, Rauwerda JA, Donker AJM, Gans ROB: Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 99:896-902, 1999.
  58. Brulez HFH, ter Wee PM, Snijders SV, Donker AJM, Verbrugh HA: Mononuclear leucocyte function tests in the assessment of the biocompatibility of peritoneal dialysis fluids. J Clin Pathol 52:901-909, 1999.
  59. Posthuma N, ter Wee PM, Donker AJM, Dekker HA, Oe PL, Verbrugh HA: Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients. Perit Dial Int 19:334-42, 1999.
  60. Schalkwijk CG, Posthuma N, ten Brink HJ, ter Wee PM, Teerlink T: Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 19:325-33, 1999.
  61. Ter Maaten JC, Bakker SJL, Serné EH, ter Wee PM, Donker AJM, Gans ROB: Insulin’s acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin’s acute effects on proximal tubular sodium reabsorption correlate with salt sensitivity in normal subjects. Nephrol Dial Transplant 14:2357-2363, 1999.
  62. Van Guldener C, Lambert J, ter Wee PM, Donker AJM, Stehouwer CDA: Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy. Clin Nephrol 53:33-41, 2000.
  63. Ter Maaten JC, Serné EH, Statius van Eps W, ter Wee PM, Donker AJM, Gans ROB: Effects of insulin and atrial natriuretic peptide on renal tubular sodium handling in sickle cell disease. Am J Physiol Renal Physiol 278:F499-505, 2000.
  64. Posthuma N, Verbrugh HA, Donker AJM, van Dorp W, Dekker HAT, Peers EM, Oe PL, ter Wee PM: Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years. Perit Dial 20:174-180, 2000.
  65. van Teijlingen ME, Borgdorff P, van Wijhe MH, van Lambalgen TA, ter Wee PM, Tangelder GJ: In vivo visualization of hemodialysis-induced alterations in leucocyte-endothelial interactions. Kidney Int 57:2608-17,2000.
  66. Serné EH, Stehouwer CDA, ter Maaten JC, ter Wee PM, Donker AJM, Gans ROB: Birth weight relates to blood pressure and microvascular function in normal subjects. J Hypertension 18:1421-1427,2000.
  67. Schalkwijk CG, ter Wee PM, Teerlink T: Reduced 1,2-dicarbonyl compounds in bicarbonate/lactate-buffered PD fluids and PD fluids based on glucose polymers or amino acids. Perit Dial Int 20:796-8, 2000.
  68. Posthuma N, ter Wee PM, Niessen H, Donker AJM, Verbrugh HA, Schalkwijk CG: Amadori-albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin. Perit Dial Int 20 Suppl 2:S106-13, 2000.
  69. Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, Verbrugh HA: Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group. Perit Dial Int 20(suppl 2):S106-13, 2000.
  70. Nanayakkara P, Gans ROB, Reichert-Thoen J, ter Wee PM: Serous retinal detachment as an early presentation of thrombotic thrombocytopenic purpura. Eur J Int Med 11:286-8, 2000.
  71. Hadithi M, Gans RO, ter Wee PM. Massive proteinuria in a patient with chronic pyelonephritis. Nephrol Dial Transplant 15:922, 2000
  72. ter Wee PM. Chronic renal failure. Initial assessment, diagnosis and therapy. Eur Urol 37:367-377, 2000
  73. Vervloet MG, Wester JP, Oudemans-Van Straaten HM, ter Wee PM, Girbes AR. Cross-contamination of infectious disease in CVVH: a potential hazard. Intensive Care Med 26:1403, 2000
  74. Serné EH, Gans ROB, ter Maaten JC, ter Wee PM, Donker AJM, Stehouwer CDA: Capillary recruitment is impaired in essential hypertension and relates to insulin’s metabolic and vascular actions. Cardiovas Res 49:161-168, 2001.
  75. van Tellingen A, Grooteman MPC, Bartels PCM, van Limbeek J, van Guldener C, ter Wee PM, Nubé MJ: Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients. Kidney Int 59:342-7, 2001.
  76. Zareie M, Hekking LH, Driesprong BA, ter Wee PM, Beelen RH, van den BJ. Accumulation of omental mast cells during peritoneal dialysis. Perit Dial Int 21 Suppl 3:S373-S376, 2001
  77. de Fijter CW, ter Wee PM, Oe LP, Verbrugh HA. Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial). Perit Dial Int 21:480-486, 2001.
  78. Hekking LH, Zareie M, Driesprong BA, Faict D, Welten AG, de G, I et al. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol 12:2775-2786, 2001.
  79. Weijmer MC, Kars SM, ter Wee PM. A scanning electron microscopy analysis of a spontaneous hemodialysis catheter fracture. Am J Kidney Dis 2001; 38:858-861
  80. Posthuma N, ter Wee PM, Niessen H, Donker AJ, Verbrugh HA, Schalkwijk CG. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin. Perit Dial Int 21:43-51, 2001.
  81. Zareie M, van Lambalgen AA, De Vriese AS, van Gelderop E, Lameire N, ter Wee PM et al. Increased leukocyte rolling in newly formed mesenteric vessels in the rat during peritoneal dialysis. Perit Dial Int 22:655-662, 2002.
  82. Weijmer MC, Debets-Ossenkopp YJ, Van De Vondervoort FJ, ter Wee PM. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 17:2189-2195, 2002.
  83. Straver B, De Vries PM, Donker AJ, ter Wee PM. The effect of profiled hemodialysis on intradialytic hemodynamics when a proper sodium balance is applied. Blood Purif 20:364-369, 2002.
  84. van Tellingen A, Grooteman MP, Pronk R, van Loon J, Vervloet MG, ter Wee PM et al. Lipopolysaccharide concentrations during superflux dialysis using unfiltered bicarbonate dialysate. ASAIO J 48:383-388, 2002.
  85. Weijmer MC, ter Wee PM. Temporary vascular access for hemodialysis treatment. Current guidelines and future directions. Contrib Nephrol 137:38-45, 2002.
  86. van Rodijnen WF, van Lambalgen TA, van Wijhe MH, Tangelder GJ, ter Wee PM. Renal microvascular actions of angiotensin II fragments. Am J Physiol Renal Physiol 283:F86-F92, 2002.
  87. van Rodijnen WF, van Lambalgen TA, Tangelder GJ, van Dokkum RP, Provoost AP, ter Wee PM. Reduced reactivity of renal microvessels to pressure and angiotensin II in fawn-hooded rats. Hypertension 39:111-115, 2002.
  88. Welten AG, Schalkwijk CG, ter Wee PM, Meijer S, van den BJ, Beelen RJ. Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response. Perit Dial Int 23:213-221, 2003.
  89. Stam F, van Guldener C, Schalkwijk CG, ter Wee PM, Donker AJ, Stehouwer CD. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 18:892-898, 2003.
  90. Weijnen TJ, van Hamersvelt HW, Just PM, Struijk DG, Tjandra YI, ter Wee PM et al. Economic impact of extended time on peritoneal dialysis as a result of using polyglucose: the application of a Markov chain model to forecast changes in the development of the ESRD programme over time. Nephrol Dial Transplant 18:390-396, 2003.
  91. de Jonge P, Ruinemans GM, Huyse FJ, Ter Wee PM: A simple risk score predicts poor quality of life and non-survival at 1 year follow-up in dialysis patients. Nephrol.Dial.Transplant. 18:2622-2628, 2003
  92. Dratwa M, Wilkie M, Ryckelynck JP, Ter Wee PM, Rutherford P, Michel C, Hopwood A, Curtis L, Denys N, Divino Filho JC, Faict D: Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis. Kidney Int.Suppl S105-S113, 2003
  93. Ter Wee PM, Beelen RH, van den BJ: The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions. Kidney Int.Suppl S75-S83, 2003
  94. van Teijlingen ME, Nube MJ, Ter Wee PM, van Wijhe MH, Borgdorff P, Tangelder GJ: Haemodialysis-induced pulmonary granulocyte sequestration in rabbits is organ specific. Nephrol.Dial.Transplant.18:2589-2595, 2003
  95. Welten AG, Schalkwijk CG, Ter Wee PM, Meijer S, van den BJ, Beelen RJ: Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response. Perit.Dial.Int. 23:213-221, 2003
  96. Zareie M, Hekking LH, Welten AG, Driesprong BA, Schadee-Eestermans IL, Faict D, Leyssens A, Schalkwijk CG, Beelen RH, Ter Wee PM, van den BJ: Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. Nephrol.Dial.Transplant. 18:2629-2637, 2003
  97. Bots CP, Brand HS, Veerman EC, Valentijn-Benz M, Van Amerongen BM, Valentijn RM, Vos PF, Bijlsma JA, Bezemer PD, Ter Wee PM, Amerongen AV: Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst. Kidney Int. 66:1662-1668, 2004
  98. le Poole CY, van Ittersum FJ, Weijmer MC, Valentijn RM, Ter Wee PM: Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study. Adv.Perit.Dial. 20:170-176, 2004
  99. Simsek S, Ter Wee PM: Klebsiella pneumoniae and pneumoperitoneum. Lancet 364:1172, 2004
  100. Stam F, van Guldener C, Ter Wee PM, Kulik W, Smith DE, Jakobs C, Stehouwer CD, de Meer K: Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine. Am.J.Physiol Renal Physiol 287:F215-F223, 2004
  101. van de Kerkhof J, Schalkwijk CG, Konings CJ, Cheriex EC, van der Sande FM, Scheffer PG, Ter Wee PM, Leunissen KM, Kooman JP: Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients. Nephrol.Dial.Transplant. 19:910-916, 2004
  102. van Tellingen A, Grooteman MP, Schoorl M, Ter Wee PM, Bartels PC, Schoorl M, van der PT, Nube MJ: Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers. Nephrol.Dial.Transplant. 19:1198-1203, 2004
  103. Weijmer MC, Ter Wee PM: Temporary vascular access for hemodialysis treatment. Current guidelines and future directions. Contrib.Nephrol. 142:94-111, 2004
  104. Weijmer MC, Vervloet MG, Ter Wee PM: Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol.Dial.Transplant. 19:670-677, 2004
  105. Zareie M, Keuning ED, Ter Wee PM, Beelen RH, van den BJ: Improvement of a chronic rat model for peritoneal dialysis by using heparin-coated catheters. Adv.Perit.Dial. 20:150-154, 2004
  106. Bots CP, Brand HS, Veerman EC, Korevaar JC, Valentijn-Benz M, Bezemer PD, Valentijn RM, Vos PF, Bijlsma JA, Ter Wee PM, van Amerongen BM, Nieuw Amerongen AV: Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysis. Nephrol.Dial.Transplant. 20:578-584, 2005
  107. Netelenbos JC, Zwijnenburg PJ, Ter Wee PM: Risk factors determining active urinary stone formation in patients with urolithiasis. Clin.Nephrol. 63:188-192, 2005
  108. Penne EL, Blankestijn PJ, Bots ML, Van den Dorpel MA, Grooteman MP, Nube MJ, Ter Wee PM: Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study. Semin.Dial. 18:47-51, 2005
  109. Penne EL, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nube MJ, Ter Wee PM: Resolving Controversies Regarding Hemodiafiltration versus Hemodialysis: The Dutch Convective Transport Study. Semin.Dial. 18:47-51, 2005
  110. Stam F, van Guldener C, Ter Wee PM, Jakobs C, de Meer K, Stehouwer CD: Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease. Kidney Int. 67:259-264, 2005
  111. van Tellingen A, Schalkwijk CG, Teerlink T, Barto R, Grooteman MP, van der PT, Ter Wee PM, Nube MJ: Influence of different haemodialysis modalities on AGE peptide levels: intradialytic versus long-term results. Nephron Clin.Pract. 100:c1-c7, 2005
  112. Zareie M, De Vriese AS, Hekking LH, Ter Wee PM, Schalkwijk CG, Driesprong BA, Schadee-Eestermans IL, Beelen RH, Lameire N, van den Born J: Immunopathological changes in a uraemic rat model for peritoneal dialysis. Nephrol.Dial.Transplant. 20:1350-1361, 2005
  113. Zareie M, Keuning ED, Ter Wee PM, Beelen RH, van den Born J: Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats. Nephrol.Dial.Transplant. 20:189-193, 2005
  114. Zareie M, van Lambalgen AA, Ter Wee PM, Hekking LH, Keuning ED, Schadee-Eestermans IL, Faict D, Degreve B, Tangelder GJ, Beelen RH, van den Born J: Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid. Perit.Dial.Int. 25:58-67, 2005
  115. Bots CP, Brand HS, Veerman EC, Valentijn-Benz M, Van Amerongen BM, Nieuw Amerongen AV, Valentijn RM, Vos PF, Bijlsma JA, Bezemer PD, Ter Wee PM: The management of xerostomia in patients on haemodialysis: comparison of artificial saliva and chewing gum. Palliat.Med. 19:202-207, 2005
  116. Grooteman MP, Gritters M, Wauters IM, Schalkwijk CG, Stam F, Twisk J, Ter Wee PM, Nube MJ: Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients. Nephrol.Dial.Transplant. 2005
  117. le Poole CY, Welten AG, Weijmer MC, Valentijn RM, van Ittersum FJ, Ter Wee PM: Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious. Perit.Dial.Int. 25 Suppl 3:S64-S68, 2005
  118. Nanayakkara PW, Teerlink T, Stehouwer CD, Allajar D, Spijkerman A, Schalkwijk C, Ter Wee PM, van Guldener C: Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure. Kidney Int. 68:2230-2236, 2005
  119. Schalkwijk CG, Ter Wee PM, Stehouwer CD: Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction. Ann.N.Y.Acad.Sci. 1043:662-670, 2005
  120. van Ittersum FJ, Ter Wee PM: New PD fluids: what studies do we need? Perit.Dial.Int. 25:438-440, 2005
  121. Weijmer MC, van den Dorpel MA, Van de Ven PJ, Ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ: Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J.Am.Soc.Nephrol. 16:2769-2777, 2005
  122. Zareie M, Tangelder GJ, Ter Wee PM, Hekking LH, van Lambalgen AA, Keuning ED, Schadee-Eestermans IL, Schalkwijk CG, Beelen RH, van den Born J: Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD. Nephrol.Dial.Transplant. 2005
  123. Zareie M, Keuning ED, Ter Wee PM, Schalkwijk CG, Beelen RH, van den Born J: Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH. Nephrol.Dial.Transplant., 21:208-216, 2006
  124. Stam F, Schalkwijk CG, van GC, Ter Wee PM, Stehouwer CD. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals. Nephrol Dial Transplant 21:677-82, 2006
  125. Ter Wee PM. Simultaneous removal and reinsertion of peritoneal dialysis catheters: do we know why and when? Perit Dial Int  25:545-6, 2005
  126. van Tellingen A, Schalkwijk CG, Teerlink T, Barto R, Grooteman MP, van der PT et al. Influence of different haemodialysis modalities on AGE peptide levels: intradialytic versus long-term results. Nephron Clin Pract 100:c1-c7, 2005
  127. Zareie M, Keuning ED, Ter Wee PM, Schalkwijk CG, Beelen RH, van den BJ. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH. Nephrol Dial Transplant 21:208-16, 2006
  128. Simsek S, de V, X, Jol JA, Spoelstra-de Man AM, Nanayakkara PW, Smulders YM et al. Sino-nasal bony and cartilaginous destruction associated with cocaine abuse, S. aureus and antineutrophil cytoplasmic antibodies. Neth J Med 64:248-51,2006
  129. Fabbrini P, Zareie M, Ter Wee PM, Keuning ED, Beelen RH, van den BJ. Peritoneal exposure model in the rat as a tool to unravel bio(in)compatibility of PDF. Nephrol Dial Transplant 21 Suppl 2:ii8-11, 2006
  130. Boeschoten EW, Ter Wee PM, Divino J. Peritoneal dialysis-related infections recommendations 2005--an important tool for quality improvement. Nephrol Dial Transplant 21 Suppl 2:ii31-3, 2006
  131. Thang OH, Jaspars EH, Ter Wee PM. Necrotizing mastitis caused by calciphylaxis. Nephrol Dial Transplant 21:2020-1,2006
  132. Roos MH, van Rodijnen WF, van Lambalgen AA, Ter Wee PM, Tangelder GJ. Renal microvascular constriction to membrane depolarization and other stimuli: pivotal role for rho-kinase. Pflugers Arch 452:471-7,2006
  133. Zareie M, Fabbrini P, Hekking LH, Keuning ED, Ter Wee PM, Beelen RH et al. Novel role for mast cells in omental tissue remodeling and cell recruitment in experimental peritoneal dialysis. J Am Soc Nephrol 17:3447-57,2006
  134. Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D et al. EBPG on Vascular Access. Nephrol Dial Transplant 22 Suppl 2:ii88-ii117, 2007
  135. Tattersall J, Martin-Malo A, Pedrini L, Basci A, Canaud B, Fouque D et al. EBPG guideline on dialysis strategies. Nephrol Dial Transplant 22 Suppl 2:ii5-ii21, 2007
  136. Fouque D, Vennegoor M, Ter WP, Wanner C, Basci A, Canaud B et al. EBPG Guideline on Nutrition. Nephrol Dial Transplant  22 Suppl 2:ii45-ii87, 2007
  137. Kooman J, Basci A, Pizzarelli F, Canaud B, Haage P, Fouque D et al. EBPG guideline on haemodynamic instability. Nephrol Dial Transplant 22 Suppl 2:ii22-ii44, 2007
  138. Bots CP, Brand HS, Veerman EC, Valentijn-Benz M, Henskens YM, Valentijn RM et al. Acute effects of hemodialysis on salivary flow rate and composition. Clin Nephrol 67:25-31, 2007
  139. Bots CP, Brand HS, Poorterman JH, Van Amerongen BM, Valentijn-Benz M, Veerman EC et al. Oral and salivary changes in patients with end stage renal disease (ESRD): a two year follow-up study. Br Dent J 27;202:E3, 2007
  140. van Rodijnen WF, Korstjens IJ, Legerstee N, Ter Wee PM, Tangelder GJ. Direct vasoconstrictor effect of prostaglandin E2 on renal interlobular arteries: role of the EP3 receptor. Am J Physiol Renal Physiol 292:F1094-F1101, 2007
  141. Nanayakkara PW, van GC, Ter Wee PM, Scheffer PG, van Ittersum FJ, Twisk JW et al. Effect of a Treatment Strategy Consisting of Pravastatin, Vitamin E, and Homocysteine Lowering on Carotid Intima-Media Thickness, Endothelial Function, and Renal Function in Patients With Mild to Moderate Chronic Kidney Disease: Results From the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study. Arch Intern Med 25;167:1262-70, 2007
  142. Celie JW, Reijmers RM, Slot EMBeelen RH, Spaargaren M, ter Wee PM, Florquin S, van den Born J. Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria. Am J Physiol Renal Physiol 294:F253-F263, 2008
  143. Farhat K, van Ittersum FJ, Fabbrini P et al.: The first weeks on peritoneal dialysis: effects on clinical parameters. Adv Perit Dial 23:102-106, 2007
  144. Nurmohamed SA, Vervloet MG, Girbes AR et al.: Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study. Blood Purif 25:316-323, 2007
  145. Roos MH, Eringa EC, van Rodijnen WF et al.: Preglomerular and postglomerular basal diameter changes and reactivity to angiotensin II in obese rats. Diabetes Obes Metab, 2007
  146. Ter Wee PM, van Ittersum FJ: The new peritoneal dialysis solutions: friends only, or foes in part? Nat Clin Pract Nephrol 3:604-612, 2007
  147. van der Weerd NC, Penne EL, van den Dorpel MA et al.: Haemodiafiltration: Promise for the Future? Nephrol Dial Transplant, 2007
 
Letters
  1. ter Wee PM, Rosman JB, van der Geest S. Acute renal failure due to diltiazem (letter). Lancet ii: 1337-1338, 1984.
  2. ter Wee PM, van Ballegooie E, Donker AJM. Increased glomer­ular filtration rate and kidney size in diabetes (letter). N Eng J Med 313:1023-1024, 1985.
  3. ter Wee PM, Gans ROB: Reply. Nephrol Dial Transpl 13:2976, 1998.
  4. Posthuma N, van Eps RS, ter Wee PM: Hemoperitoneum due to (hepatocellular) adenoma. Perit Dial Int Perit Dial Int 18:446-447, 1998.
  5. Hadithi M, Gans ROB, ter Wee PM: Massive proteinuria in a patient with chronic pyelonephritis. Nephrol Dial Transpl 15,922: 2000.
  6. Vervloet MG, Wester JPJ, Oudemans-van Straaten HM, ter Wee PM, Gerbis ARJ: Cross-contamination of infectious disease in CVVH: a potential hazard. Int Care Med 2000 (in press)
  7. de Fijter CWH, ter Wee PM, Donker AJM: The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transpl 15:1094-5, 2000.
  8. Bots CP, Brand HS, Veerman EC, Valentijn-Benz M, van Amerongen BM, Valentijn RM, Bijlsma JA, Bezemer PD, Ter Wee PM, Nieuw AV: Reply from the authors. Kidney Int. 67:1192-1193, 2005
 

Dutch papers (peer-reviewed)

  1. Polderman JA, ter Wee PM, van Goor H, Janssens J. Postmeno­pau­zale bloedingen; epidemiologische aspecten en histologi­sche diagnosen. Ned Tijdschr Geneeskd 129: 500-504, 1985.
  2. de Vries EGE, van der Geest S, ter Wee PM. De invloed van de samenstelling van de voeding, in het bijzonder eiwit en energie, op het metaboliseren van medicijnen door de mens. Voeding 48: 237-239, 1987.
  3. ter Wee PM. Vertraagt een eiwitbeperkt dieet het ­verlies van nier­functie wel? Ned Tijdschr Geneesk 1992; 136: 1287-1290.
  4. ter Wee PM. Vertraagt een eiwitbeperkt de progressie van nierfunktieverlies wel? Ned Tijdschr Geneesk 1992: 136: 2143-2144.
  5. Posthuma N, van den Berg FG, ter Wee PM. Urinewegen niet verwijd, toch verstopt. Ned Tijdschr Geneesk 137:169-173, 1993.
  6. Gans ROB, ter Wee PM: Niet-medicamenteuze adviezen bij niet van insuline-afhankelijke diabetes mellitus met hypertensie. Ned Tijdschr Diëtisten 50:210-212, 1995.
  7. ter Wee PM, Gans ROB: Waarom ontstaan nierfalen bij diabetes mellitus? Ned Tijdschr Diëtisten 50:220-223, 1995.
  8. Ter Wee PM, Donker AJM: Eiwitbeperking bij chronisch nierfalen. Een eiwitbeperkt dieet is nuttig om achteruitgang van nierfunctie te vertragen bij patiënten met chronisch nierfalen. Ned Tijdschr Diëtisten 52:184-188, 1997.
  9. Smorenburg CH, ter Wee PM, Gans ROB: Klinische toepassing van albumine: indicaties nader bekeken. Ned Tijdschr Geneesk 141:719-723, 1997.
  10. Timmers GJ, Schouten JA, ter Wee PM, Gans ROB: Hypertensie bij de negroïde patiënt: complicaties, pathogenese en therapie. Ned Tijdschr Geneesk 143:229-234, 1999.
  11. Ter Wee PM: [Chronic renal insufficiency: refer in time]. Ned.Tijdschr.Geneeskd. 148:697-700, 2004
  12. Ter Wee PM, Jorna AT: [Treatment of patients with chronic renal insufficiency; a guideline for internists]. Ned.Tijdschr.Geneeskd. 148:719-724, 2004
  13. Penne EL, Blankestijn PJ, Bots ML et al. [New study evaluating online haemodiafiltration for the reduction of cardiovascular morbidity and mortality in patients undergoing chronic haemodialysis]. Ned Tijdschr Geneeskd 2006; 150: 1583-1585
 

Chapters in books (English)

  1. de Fijter CWH, Oe PL, ter Wee PM, van der Meulen J, Donker AJM. New strategies enhance the role of peritoneal dialysis in renal replacement therapy. In: Andreucci VE, Dal Canton A (eds.). New Therapeutic Strategies in Nephrology. Kluwer Academic Publi­sh­ers, Boston, 378-80, 1991.
  2. de Fijter CWH, Oe PL, Dijkema ARA, Dwars BJ, Vos GA, ter Wee PM, van der Meulen J, Donker AJM. Peritoneal dialysis cathe­ters: peritoneoscopic insertion versus the standard surgical proce­dure. In: Ota K, et al. (eds). Current con­cepts in peritoneal dialysis.  Elsevier Science Publishers, Amsterdam 175-178, 1992.
  3. de Fijter CWH, Oe PL, Van der Meulen J, Verbrugh HA, ter Wee PM, Verhoef J, Donker AJM. A dramatic decrease in complicated peri­tonitis episodes due to staphylococcus epidermidis by changing the initial antibiotic treatment. In: Ota K, et al. (eds). Current concepts in peritoneal dialysis. Elsevier Science Publishers, Amsterdam 372-375, 1992.
  4. de Fijter CWH, Oe PL, Strijers RLM, van der Meulen, ter Wee PM, Donker AJM. The course of uremia-associated peripheral neuropa­thy: chronic peritoneal dialysis versus chronic hemodi­aly­sis. In: Ota K, et al. (eds). Current concepts in peritone­al dialysis.  Elsevier Science Publishers, Amster­dam 593-597, 1992
  5. ter Wee PM. Initial management of chronic renal failure. In: Cameron JS, Davison AM, Grünfeld J-P, Kerr DNS, Ritz E (eds.). Oxford Textbook of Clinical Nephrology. Oxford Univer­sity press, Oxford 1173-1191, 1992.
  6. ter Wee PM, Donker AJM: Renal reserve filtration capacity is well-preserved with aging in control and uninephrectomi­zed subjects.  In: Puschett JB, Greenberg A: Diuretics IV.  Chemis­try, Pharmacology and Clinical applications.  Excerp­ta Medica Intern. Congress Series (Elsevier, Amsterdam) 1023:663-666, 1993.
  7. ter Wee PM, Donker AJM: Renal reserve filtration capacity: can it predict progression of chronic renal failure?  In: Puschett JB, Greenberg A: Diuretics IV.  Chemistry, Pharma­cology and Clinical applications.  Excerpta Medica Intern. Congress Series (Elsevier, Amsterdam) 1023:653-661, 1993.
  8. ter Wee PM, Gans ROB: Diabetic renal disease: the role of haemodynamic changes.  In: Bilo HJG, Viberti GC (eds): Diabet­ic Nephropathy.  De Weezenlanden Series, Zwolle 2:103-113, 1994.
  9. Cassidy MJD, ter Wee PM. The assessment and initial management of the patient with failing renal function. In: Davison AM, Cameron JS, Grünfeld J-P, Kerr DNS, Ritz E, Winearls CG (eds.). Oxford Textbook of Clinical Nephrology. Oxford Univer­sity press, Oxford 1789-1819, 1997.
  10. Gans ROB, ter Wee PM. Regulatory mechanisms of fluid and electrolyte turnover. In: R. Bellomo, R. Bellomo (eds.). Critical Care Nephrology. Kluwer Academic Publishers, Netherlands 163-173, 1997.
  11. Ter Wee PM. Chronic renal failure. Initial Assessment, diagnosis and therapy. Eur Urol 37/3 (Curric Urol 5.5:1-11), 2000.
  12. Bilo HJG, ter Wee PM, Gans ROB. Pathogenesis of diabetic nephropathy: haemodynamic alterations. In: Hasslacher, C (ed). Wiley, Chicester, UK 59-70, 2001.
  13. Cassidy MJD, ter Wee PM. Assessment and initial management of the patient with failing renal function. In: Davison AM, Cameron JS, Grünfeld J-P, Ponticelli C, Ritz E, Winearls CG, van Ypersele C (eds.). Oxford Textbook of Clinical Nephrology. Oxford Univer­sity press, Oxford 1687-1716, 2005.

 

Chapters in books (Dutch

  1. Donker AJM, Gans ROB, Hoorntje SJ, Kootte AMM, ter Wee PM. Ziekten van nieren en urinewegen. In: Meinders AE, Boogaerts MA, Donker AJM, Erkelens DW, Schalekamp MADH, Vermeij P. Therapie in de Interne Geneeskunde. Wetensch Uitgeverij Bunge, Utrecht 691-760, 1992.
  2. Gans ROB, ter Wee PM: Hypertensie en microalbuminurie: pathogenese en behandeling.  In: Bilo HJG, Meyboom - de Jong B, van Ballegooie E (eds): Transmurale zorgvormen van diabetes mellitus: een verkenning van de Nederlandse situatie.  De Weezenlanden Series, Zwolle 10:212-223, 1996.
  3. Bilo HJG, ter Wee PM, Gans ROB: ACE-remming en diabetische nefropathie: méér dan alleen effect op bloeddruk? In: Bilo HJG, Meyboom - de Jong B, van Ballegooie E (eds): Transmurale zorgvormen van diabetes mellitus: een verkenning van de Nederlandse situatie.  De Weezenlanden Series, Zwolle 11:27-34, 1996.
  4. Gans ROB, ter Wee PM: Hypertensie en microalbuminurie: pathogenese en behandeling.  In: Bilo HJG, Meyboom - de Jong B, van Ballegooie E (eds): Transmurale zorgvormen van diabetes mellitus: een verkenning van de Nederlandse situatie.  De Weezenlanden Series, Zwolle 11:71-82, 1996.
  5. Ter Wee PM, Luitingh-van der Veen JM: Acute Nierinsufficiëntie. In: Geerts-van der Weij ACW, van Binsbergen JJ, van Dommelen-van Wamelen JA, Douwes AC, Poen H, de Vries JHM (eds.): Informatorium voor voeding en diëtetiek. Bohn Stafleu Van Loghum, Houten Va1-Va6, 1997.
  6. Ter Wee PM, Luitingh-van der Veen JM: Chronische Nierinsufficiëntie. In: Geerts-van der Weij ACW, van Binsbergen JJ, van Dommelen-van Wamelen JA, Douwes AC, Poen H, de Vries JHM (eds.): Informatorium voor voeding en diëtetiek. Bohn Stafleu Van Loghum, Houten Va7-Va12b, 1997.
  7. Ter Wee PM: Nefrotisch syndroom. In: Geerts-van der Weij ACW, van Binsbergen JJ, van Dommelen-van Wamelen JA, Douwes AC, Poen H, de Vries JHM (eds.): Informatorium voor voeding en diëtetiek. Bohn Stafleu Van Loghum, Houten Va27-Va32, 1997.
  8. Ter Wee PM: Nierstenen. In: Geerts-van der Weij ACW, van Binsbergen JJ, van Dommelen-van Wamelen JA, Douwes AC, Poen H, de Vries JHM (eds.): Informatorium voor voeding en diëtetiek. Bohn Stafleu Van Loghum, Houten Va33-Va38, 1997.
  9. Donker AJM, Gans ROB, Hoorntje SJ, Kootte AMM, ter Wee PM. Ziekten van nieren en urinewegen. In: Meinders AE, Boogaerts MA, Donker AJM, Erkelens DW, Schalekamp MADH, Vermeij P. Therapie in de Interne Geneeskunde. Wetensch Uitgeverij Bunge, Utrecht 751-821, 1997.
  10. Ter Wee PM, Gans ROB. Hart- en vaatziekten bij chronische nierinsufficiëntie. In: Büller HR, Kastelein JJP, Stroes ESG. Vasculaire Geneeskunde. Van Zuiden, Alphen aan de Rijn 145-159, 2002.
  11. Donker AJM, ten Berge RJM, Gans ROB, Hoorntje SJ, ter Wee PM. Ziekten van nieren en urinewegen. In: Meinders AE, Boogaerts MA, Erkelens DW, Vermeij P, Donker AJM, Schalekamp MADH. Therapie in de Interne Geneeskunde. Elsevier Gezondheidszorg, Maarssen 707-776, 2003.
  12. Ter Wee PM, Gans ROB. Hart-en vaatziekten bij chronische nierinsufficiëntie. In: Büller HR, Kastelein JJP, Stroes ESG. Vasculaire geneeskunde.Van Zuiden Communications BV, Alphen aan den Rijn, 167-180, 2004.
  13. Heimans JJ, ter Wee PM. Hoofdpijn. In: Thijs LG, Delooz HH, Goris RJA, Shers HJ. Acute geneeskunde. Een probleemgerichte benadering. Elsevier Gezondheidszorg, Maarssen 159-167, 2005
  14. Ter Wee PM. Oligurie, anurie en polyurie. In: Thijs LG, Delooz HH, Goris RJA, Shers HJ. Acute geneeskunde. Een probleemgerichte benadering. Elsevier Gezondheidszorg, Maarssen 215-225, 2005.

 

Books

  • Ter Wee PM. Renal reserve filtration capacity in man. Thesis. Groningen, The Netherlands, 1987.
  • Donker AJM, ter Wee PM, Weening JJ, Wilmink JM. Nierziekten en milieu intérieur - een werkboek. Bohn Stafleu Van Loghum, Houten/Diegem 1996.
  • Ter Wee PM. Current opinions in Nephrology. Research opinions topics of A.J.M. Donker revisited. VU Uitgeverij Amsterdam 2000.
 

Other publications

  • Ter Wee PM: Diabetes mellitus en hoge bloeddruk. Novo Industri BV, Amsterdam 1989
  • Ter Wee PM: Diabetische nefropathie. In: Heine RJ: Diabetes mellitus in vogelvlucht; aspecten van multidisciplinaire diabeteszorg. Van Zuiden Communications BV, Alphen a/d Rijn 63-70, 1997.
  • Leunissen KML, van den Dorpel MA, ter Wee PM: Hypotensie tijdens dialyse. Jannsen-Cilag Medisch Wetenschappelijk nieuws 82-88, 1998.
  • Ter Wee PM: Diabetische nefropathie. In: Heine RJ: Diabetes mellitus in vogelvlucht; aspecten van multidisciplinaire diabeteszorg. Van Zuiden Communications BV, Alphen a/d Rijn 2000.
  • Ter Wee PM: Diabetische nefropathie. In: Heine RJ: Diabetes mellitus in vogelvlucht; aspecten van multidisciplinaire diabeteszorg. Van Zuiden Communications BV, Alphen a/d Rijn 2005.
 
Memberships
  • Nederlandse Vereniging voor Nefrologie
  • Nederlandse Internisten Vereniging
  • Dialyse Groep Nederland
  • European Dialysis and Transplantation Association
  • International Society of Nephrology
  • American Society of Nephrology
  • American Society of Hypertension
  • International Society of Peritoneal Dialysis
  • National Kidney Foundation
  • Gesellschaft für Nephrologie

Reviewer for

  • Nephrology Dialysis Transplantation
  • Kidney International
  • Journal American Society of Nephrology
  • American Journal of Kidney Diseases
  • Peritoneal Dialysis International
  • Blood Purification